VPA与PICC在肿瘤化疗患者中应用的系统评价再评价  被引量:2

Overviews of reviews of the application of VPA and PICC in chemotherapy for tumor patients

在线阅读下载全文

作  者:张仑[1] 陈瑞[2] 宋蓓[1] ZHANG Lun;CHEN Rui;SONG Bei(Department of Nursing,the First Affiliated Hospital of Xinjiang Medical University,Urumqi 830054,China;Department of Oncology,the First Affiliated Hospital of Xinjiang Medical University,Urumqi 830054,China)

机构地区:[1]新疆医科大学第一附属医院护理部,乌鲁木齐830054 [2]新疆医科大学第一附属医院肿瘤中心肿瘤一科,乌鲁木齐830054

出  处:《新疆医科大学学报》2021年第10期1192-1197,共6页Journal of Xinjiang Medical University

基  金:新疆维吾尔自治区自然科学基金(2017D01C289)。

摘  要:目的系统评价再评价相关植入式静脉输液港(venous port access,VPA)与经外周静脉穿刺置入中心静脉导管(peripherally inserted central catheter,PICC)在肿瘤化疗患者中应用效果系统评价的质量,为临床护理治疗中中心静脉置管的选择提供全面客观的证据。方法计算机检索The Co-chrane Library、PubMed、中国期刊全文数据库(CNKI)、中国生物医学文献数据库(CBM)、万方数据库(WF)、维普期刊全文数据库(VIP),检索时间截止至2019年12月,检索VPA与PICC在肿瘤化疗患者应用效果比较的相关系统评价和Meta分析,由2名研究者按照纳入标准和排除标准独立进行文献筛选及数据提取,运用AMSTAR-2工具对纳入的研究进行方法学质量的评价,应用PRISMA清单评价结局指标的质量。结果共纳入系统评价/Meta分析9篇。方法学质量评价显示:2篇中质量,4篇低质量,3篇极低质量。报告质量学评价结果显示:2篇得分21~27分,报告相对完全;5篇得分15~21分,报告有一定缺陷;2篇得分≤15分,报告有相对严重的信息缺陷。结论本次研究结果显示VPA与PICC在化疗患者中应用效果的系统评价的方法学质量及报告质量均不高。Objective This overviews is to systematically reevaluate the efficacy of implantable venous port access(VPA)and peripherally inserted central catheter(PICC)for patients with tumor chemotherapy,so as to provide compre⁃hensive and objective evidence for the selection of central venous catheterization in clinical nursing treatment.Methods The Cochrane Library,PubMed,China National Knowledge Infrastructure(CNKI)database,China Biology Medi⁃cine disc(CBMdisc),Wanfang Database,VIP database were retrieved until December 2019.The retrieval of systemat⁃ic reviews and meta-analyses with respect to the effect of application of VPA and PICC in cancer patients undergoing chemotherapy.Two investigators independently extracted the relevant informationaccording the in-and exclusive crite⁃ria.All eligible studies were evaluated for methodological quality by Preferred Reporting Items for Systematic Reviews and Meta-Analyses(PRISMA)checklist.Results Nine systematic reviews and meta-analyses were included.Based on the AMSTAR-2 tool,2 articles were rated as medium quality,4 articles as low quality and 3 articles as very low quality.PRISMA inventory showed that 2 literatures had relatively serious information defects and 5 reports had cer⁃tain defects.The 2 reports are relatively complete.Conclusion The results of this study showed that the methodologi⁃cal and reporting quality of the systematic evaluation of the efficacy of VPA and PICC in chemotherapy for cancer pa⁃tients were not high.

关 键 词:静脉输液港 中心静脉导管 化疗 系统评价再评价 

分 类 号:R779.1[医药卫生—眼科]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象